ロニンは胚形成とマウスの胚性幹細胞の多能性のために不可欠です
Marion Dejosez1, Joshua S Krumenacker, Laura Jo Zitur
1Center for Cell and Gene Therapy, Baylor College of Medicine, Houston, Texas, USA.
Cell
|July 1, 2008
まとめ
新しい多能性因子であるロニンは,初期の胚発育と胚幹細胞 (ESC) の自己再生に不可欠です. それはHCF-1と結合し,多能性の維持に表遺伝的役割を果たすことを示唆しています.
科学分野:
- 発達生物学 発達生物学について
- エピジェネティクス エピジェネティクス
- 幹細胞生物学 幹細胞生物学
背景:
- 多能性により,細胞はすべての組織型に差異化することができる.
- プラリポテンスを支配する分子機構は完全に理解されていません.
- プラリポテンシーに関与する新しい要因を特定することは,発達医学と再生医学にとって極めて重要です.
研究 の 目的:
- 新しい候補の多能性因子を特定し,特徴づけること.
- 初期の胚形成と胚性幹細胞 (ESC) の自己再生におけるこの因子の役割を調査する.
- この因子が遺伝子発現を調節する分子機構を解明する.
主な方法:
- THAPドメインを保有する新しい候補の多能性因子,ロニンについて記述した.
- ネズミの胚の発達中のロニン発現を調査した.
- マウスとESCで条件付きノックアウトと強制表現を活用した.
- HCF-1を含む結合パートナーを特定するために共免疫プレシピテーションを行いました.
主要な成果:
- ローニンはネズミの発達初期に発現し,その欠乏は植え付近死亡率と細胞内質量欠陥を引き起こす.
- ロニンの条件付きノックアウトは,ESCの増殖を止め,その強制的な表現は,差別化なしにESCの自己更新を促進します.
- ロニンは,ESCにおけるノックダウン効果を部分的に救済する.
- ローニンは,転写調節体HCF-1に直接結合する.
結論:
- ローニンは,胚形成とESC多能性の重要な要因です.
- HCF-1とのロニンの相互作用は,多能細胞における表遺伝子遺伝子の抑制における役割を示唆しています.
- この発見は,多能性および早期発達の分子調節に関する新しい洞察を提供します.
さらに関連する動画
関連する概念動画
Embryonic Stem Cells
25.9K
Embryonic stem (ES) cells are undifferentiated pluripotent cells, meaning they can produce any cell type in the body. This gives them tremendous potential in science and medicine since they can generate specific cell types for use in research or to replace body cells lost due to damage or disease.
25.9K
Induced Pluripotent Stem Cells
23.0K
Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore...
23.0K
Embryonic Stem Cells
4.5K
Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...
4.5K
Maintenance of the ES Cell State
1.9K
The cells of the blastocyst inner cell mass only remain pluripotent for a short time. This state of pluripotency and self-renewal can be maintained in embryonic stem (ES) cell culture by adding specific chemicals or growth factors to ensure the cells can continue dividing and later differentiate into different cell types. In some cases, the cells are grown on a feeder layer of differentiated cells, which provides the growth factors and extracellular matrix components necessary for stem cell...
1.9K
Somatic to iPS Cell Reprogramming
2.1K
Reprogramming alters the gene expression in somatic cells, transforming them into induced pluripotent stem (iPS) cells over several generations. Scientists can reprogram cells by introducing genes for four transcription factors—Oct4, Sox2, Klf4, and c-Myc (OSKM) by viral or non-viral methods. These factors are also known as Yamanaka factors after Shinya Yamanaka, who first generated iPS cells using mouse skin cells. Yamanaka was awarded the Nobel Prize in Physiology or Medicine in 2012...
2.1K
Methods of Nuclear Reprogramming
1.4K
Nuclear reprogramming is a process of transforming one cell type into an unrelated cell type by epigenetic changes that alter the cell’s original gene expression pattern. Such epigenetic changes force cells to express a different set of genes, which play a significant role in inducing transformation into other cell types. Nuclear reprogramming offers applications in reproductive cloning for livestock propagation and regenerative medicine — developing patient-specific cells for...
1.4K


